CVM
CVM
AMEX · Biotechnology

Cel-Sci Corp

$1.70
+0.03 (+1.80%)
As of Sep 28, 10:31 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +2,571.8% upside
Low Target $30.66
Average Target $45.42
High Target $56.99
Current Price $1.70
Current
$1.70
Target
$45.42
$30.66 $45.42 avg $56.99
Scenario Analysis
Bear Case
$30.66
1,703.5%
Low target
Base Case
$45.42
+2,571.8%
Avg target
Bull Case
$56.99
+3,252.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.83
-84.3% from high
52-Week Low
$0.89
+91.0% from low
Target vs 52W High
$45.42
+319.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%